Incidence of Many Cancers Increasing Among Younger Generations
Incidence rate ratios increased with each successive birth cohort born since 1920 for eight of 34 cancers
Mortality Risk High for Some Gleason Grade 1 Prostate Cancer Patients
Risks increased for those with percentage positive biopsies >50 percent or prostate-specific antigen >20 ng/mL
COVID-19 Vaccination May Increase Risk for Urinary Tract Symptoms
Higher proportion of those who received single dose versus three doses urinate five or more times in the night
Predictors of Nocturnal Enuresis Include Stressful Events, Toilet Training Practices
Child sex and drinking caffeine before bed are also significant predictors
Incidence of Specific, All Cancers Increased With Pesticide Use
Increased incidence seen for leukemia, non-Hodgkin lymphoma, and bladder, colon, lung, pancreatic, and all cancers
Once-Daily TAS-303 Superior to Placebo for Stress Urinary Incontinence
TAS-303 had superior efficacy to placebo at week 12 and was associated with only mild or moderate adverse events
Being at Eye Level May Benefit Clinician-Patient Interaction
Eye-level communication more effective compared with standing at the bedside of inpatients
Prostate Cancer Outcomes Comparable for Transgender Women, Cisgender Men
No significant associations seen between transgender identity and metastatic presentation, high-risk localized disease
Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer
Expression of several stress-related genes increased in prostate tumors for men living in disadvantaged neighborhoods
Out-of-Pocket Costs Considerable, Increasing for Prostate Cancer Diagnostic Testing
Costs increased between 2010 and 2020 for follow-up diagnostic testing after prostate-specific antigen-based screening
